EUVIMEDEUVIMED entdecken
Crossref

Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus

Midori Sato, Ayano Inoue, Akira Takasawa, Kumi Takasawa, Daisuke Kyuno, Yusuke Ono, Kazufumi Magara, Makoto Osanai

Medical Molecular Morphology · 2023

DOI: 10.1007/s00795-023-00353-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Molecular Morphology, 2023. Verfasst von Midori Sato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-Ku, Sapporo, 060-0061, Japan. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Precancerous Conditions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accumulated evidence has shown that endocan, which was originally called endothelial cell-specific molecule-1, is an attractive prognostic factor in a variety of cancers. However, the relevance of endocan expression in human malignancies remains to be clarified. In the present study, the expression of endocan in cervical squamous neoplasia of the uterus, including low- and high-grade squamous intraepithelial lesions (LSIL and HSIL, respectively), as well as in invasive squamous cell carcinoma was examined by immunohistochemistry. Endocan was not sufficiently expressed in the normal cervical epithelium. Endocan expression was present in LSIL cases but was limited to basal and parabasal areas of the cells. HSIL cases exhibited strong expression of endocan with widely distributed expression toward the epithelial surface. In contrast, further strong expression of endocan was not observed in patients with invasive carcinoma. This study is the first study showing increased expression of endocan in precancerous dysplastic lesions and malignancy of the cervix. The data suggest that a high expression level of endocan potentially contributes to the development of cervical squamous neoplasia of the uterus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellPrecancerous ConditionsUterine Cervical DysplasiaUterine Cervical NeoplasmsFemaleHumansImmunohistochemistryUterusNeoplasm ProteinsProteoglycans

Stichwörter der Autor:innen

Cervical squamous intraepithelial neoplasiaEndocanImmunohistochemistryRetinoic acid-metabolizing enzyme CYP26A1Squamous cell carcinomaUterus

Substanzen

ESM1 protein, humanNeoplasm ProteinsProteoglycans

Autor:innen und Institutionen

  • Department of Pathology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-Ku, Sapporo, 060-0061, Japan.
  • Cardiovascular Department, Jichi Medical University Saitama Medical Center, Saitama, 330-8503, Japan.
  • Department of Pathology, Sapporo Medical University School of Medicine, South-1, West-17, Chuo-Ku, Sapporo, 060-0061, Japan. osanaim@sapmed.ac.jp.

Zitieren

APA

Sato, M., Inoue, A., Takasawa, A., Takasawa, K., Kyuno, D., Ono, Y., Magara, K., & Osanai, M. (2023). Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus. Medical Molecular Morphology. https://doi.org/10.1007/s00795-023-00353-0

Vancouver

Sato M, Inoue A, Takasawa A, Takasawa K, Kyuno D, Ono Y, et al. Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus. Medical Molecular Morphology. 2023. doi:10.1007/s00795-023-00353-0

BibTeX
@article{Sato2023,
  author = {Sato, Midori and Inoue, Ayano and Takasawa, Akira and Takasawa, Kumi and Kyuno, Daisuke and Ono, Yusuke and Magara, Kazufumi and Osanai, Makoto},
  title = {Elevated expression of endocan in the development of cervical squamous neoplasia of the uterus},
  journal = {Medical Molecular Morphology},
  year = {2023},
  doi = {10.1007/s00795-023-00353-0}
}
Kostenlos starten →